IL-23 promotes tumour incidence and growth
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Chronic inflammation has long been associated with increased incidence of malignancy and similarities in the regulatory mechanisms have been suggested for more than a century. Infiltration of innate immune cells, elevated activities of matrix metalloproteases and increased angiogenesis and vasculature density are a few examples of the similarities between chronic and tumour-associated inflammation. Conversely, the elimination of early malignant lesions by immune surveillance, which relies on the cytotoxic activity of tumour-infiltrating T cells or intra-epithelial lymphocytes, is thought to be rate-limiting for the risk to develop cancer. Here we show a molecular connection between the rise in tumour-associated inflammation and a lack of tumour immune surveillance. Expression of the heterodimeric cytokine interleukin (IL)-23, but not of its close relative IL-12, is increased in human tumours. Expression of these cytokines antagonistically regulates local inflammatory responses in the tumour microenvironment and infiltration of intra-epithelial lymphocytes. Whereas IL-12 promotes infiltration of cytotoxic T cells, IL-23 promotes inflammatory responses such as upregulation of the matrix metalloprotease MMP9, and increases angiogenesis but reduces CD8 T-cell infiltration. Genetic deletion or antibody-mediated elimination of IL-23 leads to increased infiltration of cytotoxic T cells into the transformed tissue, rendering a protective effect against chemically induced carcinogenesis. Finally, transplanted tumours are growth-restricted in hosts depleted for IL-23 or in IL-23-receptor-deficient mice. Although many strategies for immune therapy of cancer attempt to stimulate an immune response against solid tumours, infiltration of effector cells into the tumour tissue often appears to be a critical hurdle. We show that IL-23 is an important molecular link between tumour-promoting pro-inflammatory processes and the failure of the adaptive immune surveillance to infiltrate tumours.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17 also induces proliferative signaling in keratinocytes through Act1, a major facet of its impact in psoriasis and perhaps also explaining its involvement in skin tumorigenesis”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Langowski et al., 2006
In the citing paper
“this pro-proliferative role likely contributes to the pathogenic effects of IL-17 in psoriasis, as well as potentially in skin cancer”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Langowski et al., 2006
In the citing paper
“In addition, as discussed above, IL-17 promotes proliferation of skin epithelial cells to promote tumorigenesis”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Langowski et al., 2006
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Self-citationInterleukin-12 and the regulation of innate resistance and adaptive immunity
Trinchieri, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1001 · Cited by 3,927
The Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Self-citationOppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,822
Self-citationMatrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Cited by
Items 801–900 of 1,000
Хавкин, А. И., Михайлович, Н. К., Shrayner, E. V., Shaimardanova, D. R., Veremenko, A. S., Дмитриевна, Л. И., Platonova, P. Y., Novikova, M. F., & Валерьевна, Д. В. (2023) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-220-12-148-163 · Cited by 4
Case Report: Guselkumab treatment for sintilimab-exacerbated psoriasis in a cancer patient
Ke, J., Guo, M., Zhao, X., Liu, N., Meng, Q., & Deng, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1573495 · Cited by 4
Li, B., Sun, L., Sun, Y., Zhen, L., Qi, Q., Mo, T., Wang, H., Qiu, M., & Cai, Q. (2023) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2023.07.011 · Cited by 4
May, K. F., Jinushi, M., & Dranoff, G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394296-8.00008-7 · Cited by 4
Inflammation as a Target in Prostate Cancer
Lucia, M. S., Lambert, J. R., Platz, E. A., & Marzo, A. M. D. (2010) · Springer eBooks · doi:10.1007/978-1-60327-829-4_33 · Cited by 4
“However, recent evidence suggests that the cytokine environment of tumor-associated inflammatory cells actually suppresses cell-mediated antitumor immune surveillance activities [ 55 , 56].”
BackgroundImmunosurveillance: Innate and Adaptive Antitumor Immunity
Jinushi, M., & Dranoff, G. (2007) · Elsevier eBooks · doi:10.1016/b978-012372551-6/50067-5 · Cited by 4
IL-23 enhances the malignant properties of hepatoma cells by attenuation of HNF4α
Jiang, Q., Sun, Y., Guo, Z., Chen, R., Ma, S., Fu, M., Zhu, H., Ning, Q., Lei, P., & Shen, G. (2018) · Oncotarget · doi:10.18632/oncotarget.24875 · Cited by 4
“Among these, IL-23 plays an important role in chronic inflammation and is the hub of tumor-associated inflammation and tumor immune escape [17, 28].”
BackgroundAssim, M. M., & Saheb, E. J. (2020) · Iranian Journal of Parasitology · doi:10.18502/ijpa.v15i4.4850 · Cited by 5
“Expression of IL-23 is increased in human tumors (36).”
BackgroundClinical Utility of Guselkumab in the Treatment of Moderate-to-Severe Plaque Psoriasis
Light, J. G., Su, J. J., & Feldman, S. R. (2021) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s235242 · Cited by 4
Analysis of novel embryonic factors of cattle and effects on endometrial cells in vitro
Yun, C. S., Masaka, H., Nishino, D., Horaku, S., Rahman, A. M. I., Khandoker, M., & Yamauchi, N. (2021) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2021.106696 · Cited by 4
Hu, Y., Gu, J., Wang, Y., Lin, J., Yu, H., Yang, F., Wu, S., Yin, J., Lv, H., Ji, X., et al. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c02433 · Cited by 5
Ikeda, Y., Taniguchi, K., Yoshikawa, S., Sawamura, H., Tsuji, A., & Matsuda, S. (2022) · Exploration of Medicine · doi:10.37349/emed.2022.00108 · Cited by 5
“A role of Th17 cells in tumor development has been suggested to lead to decreased tissue inflammation and/or to increased resistance for tumor growth [54].”
BackgroundShirouzono, T., Chirifu, M., Nakamura, C., Yamagata, Y., & Ikemizu, S. (2012) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309112005295 · Cited by 4
“In addition, IL-23 negatively regulates cytotoxic T-cell infiltration into malignant lesions, so that tumour cells escape immune surveillance and elimination (Langowski et al., 2006).”
BackgroundCytokine Gene Polymorphisms in Colorectal Cancer
Stanilova, S. A. (2012) · InTech eBooks · doi:10.5772/27341 · Cited by 4
“Contradictory results have been reported in studies of Langowski et al., 2006 which showed data that IL-23 promotes tumor incidence and growth in various human cancers.”
ResultUstekinumab. Neoplasias y otros aspectos de seguridad
Santos‐Juanes, J., Coto, P., & Galache, C. (2012) · Actas Dermo-Sifiliográficas · doi:10.1016/s0001-7310(12)70007-8 · Cited by 4
[Current Research of the Roles of IL-35 in Tumor Progression].
Huang, C. B., Tian, Y., Cui, Y., Xu, J., Liang, X., Yang, X. L., & Qi, D. (2016) · PubMed Central · doi:10.3779/j.issn.1009-3419.2016.04.09 · Cited by 4
Immune Stimulatory Features of Classical Chemotherapy
der Most, R. G. V., Nowak, A. K., & Lake, R. (2007) · Elsevier eBooks · doi:10.1016/b978-012372551-6/50077-8 · Cited by 5
The Role of 22 Genes Expression in Bladder Cancer by Adaptive LASSO
Shahraki, H. R., Jaberipour, M., Zare, N., & Hosseini, A. (2016) · Iranian Journal of Cancer Prevention · doi:10.17795/ijcp-5051 · Cited by 4
Ishimura, M. E., Teixeira, D., Silveira, G. D. P., Gambero, M., Gama, G. A. C., Pimenta, B. S. O., Rodrigues, E. G., & Longo‐Maugéri, I. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205148 · Cited by 4
Everaert, B., Laere, S. V., Lembrechts, R., Hoymans, V. Y., Timmermans, J., & Vrints, C. J. (2019) · Stem Cells International · doi:10.1155/2019/9545261 · Cited by 5
“IL23α has also been shown to upregulate MMP9 activity and enhance angiogenesis [19].”
BackgroundGong, H.-B., Wu, X., Pu, X., & Kang, X. (2019) · Immunological Investigations · doi:10.1080/08820139.2019.1698600 · Cited by 5
Pardoll, D. M. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00006-0 · Cited by 5
Gender affects IL-23 serum levels in the hospitalized COVID-19 infected patients.
Abbasifard, M., Arababadi, M. K., Bahrehmand, F., Bazmandegan, G., Shahrbabaki, Z. S., & Kamiab, Z. (2022) · PubMed Central · Cited by 7
Brodt, P. (2010) · Cancer metastasis · doi:10.1007/978-90-481-8833-8_10 · Cited by 4
Cellular and Molecular Mechanisms of Tumor Promotion
Sadler, C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64273-3 · Cited by 4
Remodeling of immune system functions by extracellular vesicles
Neyrinck-Leglantier, D., Tamagne, M., Rayana, R. B., Many, S., Pinheiro, M. K., Delorme, A. S., Andrieu, M., Boilard, É., Cognasse, F., Hamzeh‐Cognasse, H., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1549107 · Cited by 5
Yasavoli‐Sharahi, H., Shahbazi, R., Alsadi, N., Robichaud, S., Kambli, D. B., Izadpanah, A., Mohsenifar, Z., & Matar, C. (2024) · Cancer Medicine · doi:10.1002/cam4.70277 · Cited by 4
Zampogiannis, A., Piperi, C., Baka, M., Zoi, I., Papavassiliou, A. G., & Moschovi, M. A. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16772 · Cited by 3
Tumor Angiogenesis and Modulators
Xu, K. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.95139 · Cited by 3
Pro‐Angiogenic and Anti‐Angiogenic Effects of Phytochemicals as Nutraceuticals
Kumar, V., Ghosh, S., Saini, S., Agrawal, H., Milind, D. P., Sircar, D., & Roy, P. (2022) · Wiley eBooks · doi:10.1002/9781119746843.ch20 · Cited by 3
Markina, E. A., Tyrina, E. A., Ratushnyy, A. Y., Andreeva, E. R., & Buravkova, L. B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813746 · Cited by 4
Immune-Mediated Tumor Rejection
Wang, E., & Marincola, F. M. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7219-4_18 · Cited by 3
Ustekinumab Improves Psoriasis without Suppressing Tumor Antigen-Specific Cytotoxic T Lymphocytes
Narita, M., Nishizawa, Y., Iwaya, S., Oiwa, E., Iwabuchi, M., Uchiyama, T., Matsuyama, A., Masuko, M., & Takahashi, M. (2014) · International Archives of Allergy and Immunology · doi:10.1159/000366503 · Cited by 3
Characterization and Development of a Luminex ® -Based Assay for The Detection of Human IL-23
Rizzi, G., Zhang, Y. J., Latek, R. R., WEINER, R. S., & Rhyne, P. (2010) · Bioanalysis · doi:10.4155/bio.10.68 · Cited by 5
Role of Tumour-Associated Macrophages in the Regulation of Angiogenesis
Hughes, R., Fang, H., Muthana, M., & Lewis, C. E. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0662-4_2 · Cited by 3
“…C-type lectin-2 (Mgl2), found in inflammatory zone 1 2003 2006) are also tumour models, as well as human tumours (e.g. breast, ovarian and renal cell carci, IL-1 , IL-6, IL-23p19 and CXCL8, depending on tumour type and stage (Biswas et al. 2006; Dinapoli et al. 1996; Langowski et al. 2006).”
BackgroundTissue properties and collagen remodeling in heart valve tissue engineering
Geemen, V. D. D. (2012) · TU/e Research Portal · doi:10.6100/ir732930 · Cited by 4
Comment on: ‘Treatment of psoriasis with ustekinumab in a patient with HIV ‐related Kaposi sarcoma’
Genovese, G., Tourlaki, A., Berti, E., & Brambilla, L. (2019) · Clinical and Experimental Dermatology · doi:10.1111/ced.13935 · Cited by 3
IL-23 orchestrates the switch from tumor immune surveillance to tumor-promoting inflammation
Oft, M. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8681-8_14 · Cited by 2
“One of these inhibitors, IL-23, is significantly overexpressed in the large majority of human tumor types [ 35 ].”
BackgroundSelf-citationThe role of chemokines and interleukins in acute lymphoblastic leukemia: a systematic review
Štajer, M., Horáček, J. M., Kupsa, T., & Зак, П. (2024) · Journal of Applied Biomedicine · doi:10.32725/jab.2024.024 · Cited by 2
Intraepithelial lymphocytes in human oral diseases
Zhou, D., Bao, C., & Zhou, G. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1597088 · Cited by 3
Pascual, M. M., Dho, N. D., Strack, R. P. A., Marín, C., Moreno, F. R., Palacios, L. M., Menichetti, G., Luque, C., Crespo, M. I., Maletto, B. A., et al. (2025) · Immunology · doi:10.1111/imm.70064 · Cited by 2
“Tumours harvested from LSP1 KO mice have a higher concentration of multiple inflammatory cytokines which could contribute to tumour development, particularly taking into account that chronic inflammation has been broadly related to cancer development [77].”
Şen, M., & Eroğul, Ö. (2024) · Cureus · doi:10.7759/cureus.61089 · Cited by 2
“IL-23 plays a role in Th17 cell survival and proliferation [26, 27].”
BackgroundImmunology and Immunotherapy of Breast Cancer
Stagg, J., & Loi, S. (2015) · Springer eBooks · doi:10.1007/978-3-662-46410-6_23 · Cited by 2
Inflammation, Chronic Disease, and Cancer: Is Psychological Distress the Common Thread?
Carr, F. N., & Sosa, E. M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4866-2_2 · Cited by 2
Expression of Th17 cell population regulatory cytokines in laryngeal carcinoma – Preliminary study
Kopta, R., Mochocki, M., Morawski, P., Brzezińska‐Błaszczyk, E., Lewy‐Trenda, I., Circle, S. S., & Starska, K. (2015) · Współczesna Onkologia · doi:10.5114/wo.2015.51612 · Cited by 2
“While IL-17 can promote the cells leading to tumour regression, IL-23 contributes to the impairment of specific neoplastic cytotoxic CD8+ T lymphocytes and reduces cell infiltration into the transformed tissue [2, 6].”
BackgroundInfluentialCell Survival and Death in Rheumatic Diseases
Elkon, K. B. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-1738-9.00027-x · Cited by 4
Terayama, Y., Matsuura, T., & Ozaki, K. (2017) · Toxicologic Pathology · doi:10.1177/0192623317726193 · Cited by 2
“T cells are known to be involved in tumor promotion, progression, and metastasis, and TAMs are reported to be obligatory for angiogenesis, invasion, and metastasis (Condeelis and Pollard 2006; Hanada et al. 2006; Langowski et al. 2006; Roberts et al. 2007).”
BackgroundIL-12/23 Inhibitors and Their Potential Benefits and Risks for Psoriasis Patients
Kinney, M. A., Yentzer, B. A., & Feldman, S. R. (2010) · Psoriasis Forum · doi:10.1177/247553031016a00103 · Cited by 2
Inflammasomes and Inflammation
Chen, K. W., Richards, A. A., Zamoshnikova, A., & Schroder, K. (2014) · Wiley eBooks · doi:10.1002/9781118826621.ch8 · Cited by 2
Inflammatory Cytokines and Their Role in Bone Metastasis and Osteolysis
Suva, L. J., Nicholas, R. W., & Gaddy, D. (2009) · Springer eBooks · doi:10.1007/978-1-84882-019-7_9 · Cited by 2
New paradigms in inflammation: where to next?
Hunter, C. A., & Kastelein, R. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00716.x · Cited by 2
“Given the data that link IL-12 to tumor surveillance and IL-23 to the promotion of cancer (17), there are general concerns about whether long-term blockade of IL-12 and/ or IL-23 renders patients more susceptible to neoplasms or opportunistic infections, and monitoring of the effects of these treatments will provide a…”
BackgroundSelf-citationOmega-3 Fatty Acids in Cancer Prevention and Control: A Membrane Perspective
Turk, H. F., Monk, J. M., Hou, T. Y., & Chapkin, R. S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6819-6_12 · Cited by 2
Zhang, N., Jordan, R. E., & An, Z. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1122861 · Cited by 2
A, B. A. B. (2015) · Biological Systems Open Access · doi:10.4172/2329-6577.1000132 · Cited by 2
The Role of the JAK/STAT Signalling Pathway in Immunoregulation of Gastrointestinal Cancers
Vaddi, K. (2017) · Springer eBooks · doi:10.1007/978-3-319-43063-8_7 · Cited by 3
Lewko, W. M., & Oldham, R. K. (2009) · Springer eBooks · doi:10.1007/978-90-481-2289-9_8 · Cited by 2
Psychosocial Issues in Hepatocellular Carcinoma
Steel, J. L., Carr, F. N., Savkova, A., Ahmed, N., DiMartini, A., & Dew, M. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-34214-6_36 · Cited by 2
The Cellular Microenvironment and Metastases
Giaccia, A. J., & Erler, J. T. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50006-3 · Cited by 6
Ramoner, R. E., Rahm, A., Gander, H., Stollenwerk, B., Falkensammer, C. E., Leonhartsberger, N., & Thurnher, M. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0454-0 · Cited by 2
“Moreover, IL-23 stimulated angiogenesis and antagonized IL-12 and IFN-, both of which are crucial eVector cytokines of antitumor immune responses [22, 23 ].”
BackgroundInfluentialLiu, X., Zhang, L., Zhang, X., Yu, H. N., Zhao, X., Lü, J., Qian, G., & Ge, S. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.6.1389 · Cited by 2
Self-citationSmyth, M. J. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.02.013 · Cited by 2
Evaluation of interleukin-23 expression in classic kaposi’s sarcoma and AIDS-Associated
Miranda, F. J. A., Miranda, L. N., Reginaldo, F. P. S., Mangabeira, C. D. P., Crispim, J. C. D. O., Lima, F. P., Farias, K. J. S., & Machado, P. R. L. (2024) · Revista de Patologia Tropical / Journal of Tropical Pathology · doi:10.5216/rpt.v53i1.77403 · Cited by 1
“Furthermore, it was observed that mice depleted of IL-23 cytokine and its receptor presented a reduction in the growth of transplanted tumors (Langowski et al., 2006).”
BackgroundImmunological Assessment of Key Biomarkers in Stage III Breast Cancer
Turki, S. G. (2024) · Journal of Contemporary Medical Sciences · doi:10.22317/jcms.v10i3.1579 · Cited by 1
Lawal, H. A., Raji, A. O., Olayiwola, A. E., Suleiman, Z. A., Muiz, W., Lawal, A. O., Okesanya, O. J., Ibrahim, R. B., & Oso, T. A. (2025) · Exploration of Medicine · doi:10.37349/emed.2025.1001352 · Cited by 4
Biologic Therapy and Malignancy Risk in Psoriasis: A Retrospective Cohort Study
Takamura, S., Saito, S., Sugai, S., Shiko, Y., Yamaguchi, T., Kawasaki, Y., & Fukuda, T. (2025) · The Journal of Dermatology · doi:10.1111/1346-8138.17950 · Cited by 1
Infectious microbes and spectrum of cancer: Need to sharpen the depth and broaden the width
Anand, T., & Kumar, A. (2025) · The Microbe · doi:10.1016/j.microb.2025.100615 · Cited by 1
Psoriasis-like disease prevents squamous skin tumor development by neutrophil-driven inflammation
Tsokkou, P., Holcmann, M., Rindler, K., Mieczkowski, K., Shaw, L. E., Farlik, M., Sibilia, M. C., & Wagner, E. F. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536378123 · Cited by 2
“…Langowski et al., demonstrated that genetic deletion and antibody - mediated neutralization of IL - 23 reduced tumor incidence, while Teng et al., revealed that IL - 23 sup presses innate antitumor immunity with knock - out mice being pro tected against tumor initiation and metastasis (43, 44).”
Zhou, X., Chen, Y., Li, J., Zhang, Y., Li, J., & Guo, Y. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153893 · Cited by 1
Fatty Acid Metabolism in Health and Cancer: From Fundamental Mechanisms to Therapeutic Application
Hang, N., Zhao, R., Zhang, F., Guo, D., Li, Q., Shen, Z., Gao, R., Gao, C., Xie, Z., Fu, S., et al. (2026) · MedComm · doi:10.1002/mco2.70749 · Cited by 1
TH17 Cells in the Tumor Micro-environment
Wilke, C. M., & Zou, W. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9371-7_26 · Cited by 1
Interleukin-1 Superfamily and Cancer
Yuzhalin, A. E., & Kutikhin, A. G. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801121-8.00002-6 · Cited by 2
Neue Strategien für die onkologische Therapie: Interleukine im Fokus
Jobst, J., & Kobold, S. (2021) · Deutsches Ärzteblatt · doi:10.3238/personko.2021.11.26.07 · Cited by 1
Pardoll, D. M. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50009-9 · Cited by 1
Ryan, C., & Leonardi, C. L. (2014) · Springer eBooks · doi:10.1007/978-1-4471-4432-8_15 · Cited by 1
Immunotoxicology of Biopharmaceutics
Haggerty, H. G., Price, K. D., & Shenton, J. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100601-6.02008-1 · Cited by 1
Therapeutic Gene Therapy for Cancer with Interleukin-23
Reay, J. C. (2010) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Tumor Antigens Revealed by Exome Seqeuncing Drive Editing of Tumor Immunogenicity
Vesely, M. D. (2013) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7c8278n · Cited by 2
Role of Innate Immunity in Cancers and Antitumor Response
Jinushi, M., & Baghdadi, M. (2014) · Springer eBooks · doi:10.1007/978-3-662-44006-3_3 · Cited by 2
“In contrast, IL-23 −/− mice showed reduced infl ammation and thus attenuated tumor formation [ 146 ].”
BackgroundPsychosocial Issues in Hepatocellular Carcinoma
Steel, J. L., DiMartini, A. F., & Dew, M. A. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-376-3_24 · Cited by 3
Tumour-associated macrophages (IL-23+CD14+ subset) levels during bladder cancer progression
El‐Gedamy, M. S., Abol‐Enein, H., El-Khayat, Z., Elsaid, A. M. M., & Elnahrery, I. (2021) · Frontiers in Scientific Research and Technology · doi:10.21608/fsrt.2021.56346.1030 · Cited by 1
“Of note, the tumour survival is regarded as a chaotically governed process refers to the interplay between cancerous cells and the tumour microenvironment (TME), where their activities are rerouted to benefit tumour growth.”
BackgroundInfluentialRole of microbiome in cancer immunotherapy
Russo, E., Boem, F., & Amedei, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823397-9.00010-7 · Cited by 1
Inflammation, Chronic Disease, and Cancer: Is Psychological Distress the Common Thread?
Carr, F. N., Sosa, E. M., & Carr, B. I. (2022) · Springer eBooks · doi:10.1007/978-3-030-85702-8_1 · Cited by 2
Cell Survival and Death in Rheumatic Diseases
Elkon, K. B. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3285-4.10024-5 · Cited by 1
Extracellular Matrix as a Metabolic Niche in Cancer
Sebestyén, A. R., Dankó, T., Sztankovics, D., Moldvai, D., Krencz, I., Raffay, R. E., & Petővári, G. (2022) · Biology of extracellular matrix · doi:10.1007/978-3-030-99708-3_13 · Cited by 1
Şentürk, M. (2022) · Biochemistry · doi:10.5772/intechopen.100950 · Cited by 3
“Aging Gut Microbiota and Colorectal Cancer Pathways Correlations”
Catanzaro, R., Sciuto, M., Fattahi, N., Saidpour, A., & Marotta, F. (2023) · Healthy ageing and longevity · doi:10.1007/978-3-031-14023-5_15 · Cited by 1
Cytokine Regulation of Immune Tolerance to Tumors
Li, M. O., & Flavell, R. A. (2007) · Elsevier eBooks · doi:10.1016/b978-012372551-6/50068-7 · Cited by 1
Interactions between Dietary Factors and Inflammation in Prostate Carcinogenesis
Marzo, A. M. D. (2006) · Defense Technical Information Center (DTIC) · doi:10.21236/ada468039 · Cited by 1
Touil, T. (2010) · The Open Autoimmunity Journal · doi:10.2174/1876894601002040141 · Cited by 1
The Prognostic Significance of Tumor-Infiltrating Lymphocytes
Yu, P., & Fu, Y. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6615-5_19 · Cited by 1
Katneni, U. (2015) · Library, Museums and Press - UDSpace (University of Delaware) · doi:10.58088/35gq-m967 · Cited by 4
The IL-12/IL-23 Cytokine Family
Pistoia, V. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.10013-x · Cited by 2
Molecular and Epigenetic Insights into RASSF1A Regulated Pathways in Inflammatory Bowel Disease
Salla, M. (2018) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3794195h · Cited by 1
Baird, A., Leonard, J. M., Naicker, K. M., Kilmartin, L., O'Byrne, K. J., & Gray, S. G. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.10.003 · Cited by 3
Utilizing Mouse Models of Human Cancer for Assessing Immune Modulation of Cancer Development
de Visser, K. E., & Coussens, L. M. (2011) · Springer eBooks · doi:10.1007/978-0-387-69805-2_21
Relationship Between Th17 and Regulatory T Cells in the Tumor Environment
Kryczek, I., Wu, K., Zhao, E., Wang, G., & Zou, W. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9914-6_10
Functional networks of events that modulate phenotypic manifestation of cancer
Thiagalingam, S. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9780511979811.012
Anti-tumor and pro-tumor interactions of human NK cells in cancer
Wong, J. L. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
Normanton, M. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2014.tde-22092014-163529
EFEITOS ANTITUMORAIS E HEMATOLÓGICOS IN VIVO DO COMPOSTO MESOIÔNICO SIDNONA 1
Galuppo, L. F. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Metadata
- Authors
- Langowski, J. L., Zhang, X., Wu, L., Mattson, J. D., Chen, T., Smith, K., Basham, B., McClanahan, T., Kastelein, R. A., & Oft, M.
- Corresponding author
- Oft, Martin
- Venue
- Nature
- Published
- 2006-05-10
- Volume
- 442
- Issue
- 7101
- Pages
- 461-465
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1984467626
- Cited by
- 1,018
- References
- 30
- Citations by year
- 2026: 23 · 2025: 18 · 2024: 32 · 2023: 46 · 2022: 42 · 2021: 44 · 2020: 41 · 2019: 52 · 2018: 41 · 2017: 41 · 2016: 41 · 2015: 47 · 2014: 62 · 2013: 72 · 2012: 65
- FWCI
- 24.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- IL-23, tumour-associated inflammation, tumor surveillance, CD8+ T cell infiltration, intraepithelial lymphocytes, tumor microenvironment, angiogenesis, MMP-9, IL-12, chemical carcinogenesis, IL23R, tumor growth, cancer immunotherapy
- MeSH terms
- Animals, Cell Division, Humans, Inflammation, Interleukins, Mice, Inbred C57BL, Neoplasms, Signal Transduction, CD8-Positive T-Lymphocytes, Interleukin-12, Genetic Predisposition to Disease, Mice, Interleukin-23, Interleukin-23 Subunit p19
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.